Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription 06.10.2025 4 Biol Psychiatry 1 Br J Psychiatry 1 Mol Psychiatry 3 Neuropsychopharmacology 2 Psychiatry Res 3 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. FLETCHER PC, Robbins TW
   Shining a Light on the Earliest Symptoms of Psychosis.
   Biol Psychiatry. 2025;98:652-653.
   PubMed        
   
   
2. LEE CH
   Pleiotropy in Multitrait Genome-Wide Association Studies: Approaches and Insights From Schizophrenia-Cognition Analyses.
   Biol Psychiatry. 2025;98:650-651.
   PubMed        
   
   
3. POLLAK TA
   Autoimmune Psychosis: Progress, Problems, and the Path Ahead.
   Biol Psychiatry. 2025;98:648-649.
   PubMed        
   
   
4. BRAH HS, Sran N, Sanghani S, Valmadrid L, et al
   Clinical Genetic Testing in Schizophrenia: A Systematic Review and Meta-Analysis.
   Biol Psychiatry. 2025 Sep 30:S0006-3223(25)01485.
   PubMed         Abstract available
   
   

   
   Br J Psychiatry

5. PEI H, Jiang S, Hou C, Li H, et al
   Accelerated ageing unfolds along the sensorimotor-association cortical axis in schizophrenia: multi-site study.
   Br J Psychiatry. 2025 Oct 1:1-9. doi: 10.1192/bjp.2025.10364.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

6. CARR R, Cannon A, Finelli V, Bukala B, et al
   Non-Clozapine interventions in treatment-resistant schizophrenia: a systematic review and meta-analysis.
   Mol Psychiatry. 2025 Oct 3. doi: 10.1038/s41380-025-03255.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

7. GARCIA-CERRO S, Gomez-Garrido A, Soria FN, Loucera C, et al
   Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes.
   Neuropsychopharmacology. 2025 Sep 25. doi: 10.1038/s41386-025-02210.
   PubMed         Abstract available
   
   
8. GIRGIS RR, de la Fuente-Sandoval C, Lewis-Fernandez R, Reyes-Madrigal F, et al
   Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis.
   Neuropsychopharmacology. 2025 Sep 25. doi: 10.1038/s41386-025-02251.
   PubMed         Abstract available
   
   
9. HERMS EN, Wisner KM
   Moving from isolation to integration: a Bayesian multisensory perspective of interoception and psychosis.
   Neuropsychopharmacology. 2025 Sep 24. doi: 10.1038/s41386-025-02250.
   PubMed        
   
   

   
   Psychiatry Res

10. PANGANIBAN KJ, Smith ECC, Stogios N, Agarwal SM, et al
    The cognitive metabolomic signatures in schizophrenia spectrum disorders: A systematic review.
    Psychiatry Res. 2025;353:116742.
    PubMed         Abstract available
    
    
11. SOTERO-MORENO A, Guardiola-Ripoll M, Hostalet N, Moreira M, et al
    Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophrenia.
    Psychiatry Res. 2025;353:116721.
    PubMed         Abstract available
    
    

    
    Psychol Med

12. YAO S, Mo F, Rao Z, Shi Y, et al
    Network localization of genetic risk for schizophrenia and bipolar disorder.
    Psychol Med. 2025;55:e299.
    PubMed         Abstract available
    
    
13. LIU KY, Perera G, Howard R, Mueller C, et al
    Cognitive trajectories and dementia risk in patients with schizophrenia spectrum versus affective disorders.
    Psychol Med. 2025;55:e286.
    PubMed         Abstract available
    
    
14. MICHALOPOULOU PG, Meshreky KM, Hommerich Z, Shergill SS, et al
    Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects.
    Psychol Med. 2025;55:e281.
    PubMed         Abstract available
    
    

    
    Schizophr Res

15. NOVACEK DM, Subotnik KL, Ventura J, Casaus LR, et al
    Corrigendum to "Positive symptoms and medication adherence in response to oral versus long-acting injectable risperidone in black, latino, and white first-episode psychosis patients" [Schizophr Res. (2025) 160-166].
    Schizophr Res. 2025 Oct 3:S0920-9964(25)00336.
    PubMed        
    
    
16. HIRJAK D, Volkmer S, Pokorny V, Mittal VA, et al
    Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation.
    Schizophr Res. 2025;285:185-195.
    PubMed         Abstract available
    
    
17. MOLLON J, Lanzagorta N, Mathias SR, Rodrigue A, et al
    The burden of early onset psychosis: Diagnostic complexity, high comorbidity, and poor functioning in patients and their relatives.
    Schizophr Res. 2025;285:165-174.
    PubMed         Abstract available
    
    
18. CAROL EE, Rodriguez J, Guvenek-Cokol PE, Kim HJ, et al
    Learning health systems in early interventions for psychosis: Establishing consumer voices in clinical high-risk for psychosis care.
    Schizophr Res. 2025;285:149-154.
    PubMed         Abstract available
    
    
19. DAMME KSF
    The hippocampus: At the nexus of risk and resilience for schizophrenia.
    Schizophr Res. 2025;285:141-148.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.